Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging

References

1. 1.↵
   2. Lassmann H

   . Models of multiple sclerosis: new insights into pathophysiology and repair. Curr Opin Neurol 2008;21:242–47 doi:10.1097/WCO.0b013e3282fee94a pmid:18451705

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Ontaneda D,
   3. Fox RJ,
   4. Chataway J

   . Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives. Lancet Neurol 2015;14:208–23 doi:10.1016/S1474-4422(14)70264-9 pmid:25772899

   CrossRefPubMed
3. 3.↵
   2. Fox RJ

   . Picturing multiple sclerosis: conventional and diffusion tensor imaging. Semin Neurol 2008;28:453–66 doi:10.1055/s-0028-1083689 pmid:18843574

   CrossRefPubMed
4. 4.↵
   2. Beaulieu C,
   3. Allen PS

   . Determinants of anisotropic water diffusion in nerves. Magn Reson Med 1994;31:394–400 doi:10.1002/mrm.1910310408 pmid:8208115

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Song SK,
   3. Sun SW,
   4. Ju WK, et al

   . Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003;20:1714–22 doi:10.1016/j.neuroimage.2003.07.005 pmid:14642481

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Song SK,
   3. Sun SW,
   4. Ramsbottom MJ, et al

   . Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429–36 doi:10.1006/nimg.2002.1267 pmid:12414282

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Budde MD,
   3. Kim JH,
   4. Liang HF, et al

   . Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med 2007;57:688–95 doi:10.1002/mrm.21200 pmid:17390365

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Harrison DM,
   3. Caffo BS,
   4. Shiee N, et al

   . Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis. Neurology 2011;76:179–86 doi:10.1212/WNL.0b013e318206ca61 pmid:21220722

   Abstract/FREE Full Text
9. 9.↵
   2. Goodkin DE,
   3. Rooney WD,
   4. Sloan R, et al

   . A serial study of new MS lesions and the white matter from which they arise. Neurology 1998;51:1689–97 doi:10.1212/WNL.51.6.1689 pmid:9855524

   Abstract/FREE Full Text
10. 10.↵
    2. Werring DJ,
    3. Brassat D,
    4. Droogan AG, et al

    . The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000;123(pt 8):1667–76 doi:10.1093/brain/123.8.1667 pmid:10908196

    Abstract/FREE Full Text
11. 11.↵
    2. Naismith RT,
    3. Xu J,
    4. Tutlam NT, et al

    . Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 2010;74:1694–701 doi:10.1212/WNL.0b013e3181e042c4 pmid:20498437

    Abstract/FREE Full Text
12. 12.↵
    2. Rocca MA,
    3. Cercignani M,
    4. Iannucci G, et al

    . Weekly diffusion-weighted imaging of normal-appearing white matter in MS. Neurology 2000;55:882–84 doi:10.1212/WNL.55.6.882 pmid:10994017

    Abstract/FREE Full Text
13. 13.↵
    2. Filippi M,
    3. Iannucci G,
    4. Cercignani M, et al

    . A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch Neurol 2000;57:1017–21 doi:10.1001/archneur.57.7.1017 pmid:10891984

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Ransohoff RM

    . Natalizumab for multiple sclerosis. N Engl J Med 2007;356:2622–29 doi:10.1056/NEJMct071462 pmid:17582072

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Tuch DS,
    3. Reese TG,
    4. Wiegell MR, et al

    . High angular resolution diffusion imaging reveals intravoxel white matter fiber heterogeneity. Magn Reson Med 2002;48:577–82 doi:10.1002/mrm.10268 pmid:12353272

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Landman BA,
    3. Farrell JA,
    4. Jones CK, et al

    . Effects of diffusion weighting schemes on the reproducibility of DTI-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T. Neuroimage 2007;36:1123–38 doi:10.1016/j.neuroimage.2007.02.056 pmid:17532649

    CrossRefPubMed
17. 17.↵
    2. Fox RJ,
    3. Cronin T,
    4. Lin J, et al

    . Measuring myelin repair and axonal loss with diffusion tensor imaging. AJNR Am J Neuroradiol 2011;32:85–91 doi:10.3174/ajnr.A2238 pmid:20947644

    Abstract/FREE Full Text
18. 18.↵
    2. Polman CH,
    3. Reingold SC,
    4. Edan G, et al

    . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria.” Ann Neurol 2005;58:840–46 doi:10.1002/ana.20703 pmid:16283615

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Hiltunen J,
    3. Hari R,
    4. Jousmäki V, et al

    . Quantification of mechanical vibration during diffusion tensor imaging at 3 T. Neuroimage 2006;32:93–103 doi:10.1016/j.neuroimage.2006.03.004 pmid:16682233

    CrossRefPubMed
20. 20.↵
    2. Brex PA,
    3. Parker GJ,
    4. Leary SM, et al

    . Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatry 2000;68:627–32 doi:10.1136/jnnp.68.5.627 pmid:10766895

    Abstract/FREE Full Text
21. 21.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Woolrich MW, et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;2(suppl 1):S208–19 pmid:15501092

    PubMed
22. 22.↵
    2. Wang S,
    3. Wu EX,
    4. Tam CN, et al

    . Characterization of white matter injury in a hypoxic-ischemic neonatal rat model by diffusion tensor MRI. Stroke 2008;39:2348–53 doi:10.1161/STROKEAHA.107.509927 pmid:18535275

    Abstract/FREE Full Text
23. 23.↵
    2. Kim JH,
    3. Loy DN,
    4. Liang HF, et al

    . Noninvasive diffusion tensor imaging of evolving white matter pathology in a mouse model of acute spinal cord injury. Magn Reson Med 2007;58:253–60 doi:10.1002/mrm.21316 pmid:17654597

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Castriota Scanderbeg A,
    3. Tomaiuolo F,
    4. Sabatini U, et al

    . Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. AJNR Am J Neuroradiol 2000;21:862–68 pmid:10815661

    Abstract/FREE Full Text
25. 25.↵
    2. Nusbaum AO,
    3. Lu D,
    4. Tang CY, et al

    . Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. AJR Am J Roentgenol 2000;175:821–25 doi:10.2214/ajr.175.3.1750821 pmid:10954474

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Bitsch A,
    3. Kuhlmann T,
    4. Stadelmann C, et al

    . A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 2001;49:793–96 doi:10.1002/ana.1053 pmid:11409432

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Brück W,
    3. Bitsch A,
    4. Kolenda H, et al

    . Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783–93 doi:10.1002/ana.410420515 pmid:9392578

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Rashid W,
    3. Hadjiprocopis A,
    4. Davies G, et al

    . Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging. J Neurol 2008;255:390–97 doi:10.1007/s00415-008-0678-0 pmid:18350361

    CrossRefPubMed
29. 29.↵
    2. Boretius S,
    3. Escher A,
    4. Dallenga T, et al

    . Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. Neuroimage 2012;59:2678–88 doi:10.1016/j.neuroimage.2011.08.051 pmid:21914485

    CrossRefPubMed
30. 30.↵
    2. Kuhlmann T,
    3. Lingfeld G,
    4. Bitsch A, et al

    . Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002;125:2202–12 doi:10.1093/brain/awf235 pmid:12244078

    Abstract/FREE Full Text
31. 31.↵
    2. Moll NM,
    3. Rietsch AM,
    4. Thomas S, et al

    . Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol 2011;70:764–73 doi:10.1002/ana.22521 pmid:22162059

    CrossRefPubMed
32. 32.↵
    2. Roosendaal SD,
    3. Geurts JJ,
    4. Vrenken H, et al

    . Regional DTI differences in multiple sclerosis patients. Neuroimage 2009;44:1397–403 doi:10.1016/j.neuroimage.2008.10.026 pmid:19027076

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Zivadinov R,
    3. Hussein S,
    4. Bergsland N, et al

    . Magnetization transfer imaging of acute black holes in patients on glatiramer acetate. Front Biosci (Elite Ed) 2012;4:1496–504 pmid:22201970

    PubMed
34. 34.↵
    2. Chen JT,
    3. Kuhlmann T,
    4. Jansen GH, et al

    ; Canadian MS/BMT Study Group. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. Neuroimage 2007;36:1152–58 doi:10.1016/j.neuroimage.2007.03.073 pmid:17543541

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Jones DK,
    3. Basser PJ

    . “Squashing peanuts and smashing pumpkins”: how noise distorts diffusion-weighted MR data. Magn Reson Med 2004;52:979–93 doi:10.1002/mrm.20283 pmid:15508154

    CrossRefPubMed